E-LIB Suche - Ergebnisse für: Laille, Eric

1

P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCA..:

Boissel, Nicolas ; Chevallier, Patrice ; Curran, Kevin...
HemaSphere. 7 (2023) S3 - p. e323373f , 2023

2

Population Pharmacokinetics of Oral Azacitidine, and Exposu..:

Gaudy, Allison ; Laille, Eric ; Bailey, Rochelle...
Clinical Pharmacology & Therapeutics. 114 (2023) 4 - p. 845-852 , 2023

Link: https://doi.org/10.1002/..

3

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed A..:

Rubio-San-Simón, Alba ; van Eijkelenburg, Natasha K. A. ; Hoogendijk, Raoull...
Pediatric Drugs. 25 (2023) 6 - p. 719-728 , 2023

Link: https://doi.org/10.1007/..

4

Enasidenib vs conventional care in older patients with late..:

de Botton, Stéphane ; Montesinos, Pau ; Schuh, Andre C....
Blood. 141 (2023) 2 - p. 156-167 , 2023

Link: https://doi.org/10.1182/..

5

Evaluation of the bioequivalence and food effect on the bio..:

Babiker, Hani M. ; Milhem, Mohammed ; Aisner, Joseph...
Cancer Chemotherapy and Pharmacology. 85 (2020) 3 - p. 621-626 , 2020

Link: https://doi.org/10.1007/..

6

Correction to: Evaluation of the bioequivalence and food ef..:

Babiker, Hani M. ; Milhem, Mohammed ; Aisner, Joseph...
Cancer Chemotherapy and Pharmacology. 85 (2020) 5 - p. 1009-1010 , 2020

Link: https://doi.org/10.1007/..

7

CC-486 Maintenance after Stem Cell Transplantation in Patie..:

de Lima, Marcos ; Oran, Betul ; Champlin, Richard E....
Biology of Blood and Marrow Transplantation. 24 (2018) 10 - p. 2017-2024 , 2018

Link: https://doi.org/10.1016/..

8

Extended dosing with CC‐486 (oral azacitidine) in patients ..:

Savona, Michael R. ; Kolibaba, Kathryn ; Conkling, Paul...
American Journal of Hematology. 93 (2018) 10 - p. 1199-1206 , 2018

Link: https://doi.org/10.1002/..

9

Romidepsin in Japanese patients with relapsed or refractory..:

Maruyama, Dai ; Tobinai, Kensei ; Ogura, Michinori...
International Journal of Hematology. 106 (2017) 5 - p. 655-665 , 2017

Link: https://doi.org/10.1007/..

10

Efficacy, safety and pharmacokinetics of subcutaneous azaci..:

Du, Xin ; Lai, Yue‐Yun ; Xiao, Zhijian...
Asia-Pacific Journal of Clinical Oncology. 14 (2017) 3 - p. 270-278 , 2017

Link: https://doi.org/10.1111/..

11

Efficacy, safety, and pharmacokinetics of subcutaneous azac..:

Chou, Wen‐Chien ; Yeh, Su‐Peng ; Hsiao, Liang‐Tsai...
Asia-Pacific Journal of Clinical Oncology. 13 (2017) 5 - p. , 2017

Link: https://doi.org/10.1111/..

12

CC-486 (Oral Azacitidine) Maintenance Therapy Is Well Toler..:

de Lima, Marcos ; Oran, Betul ; Papadopoulos, Esperanza B....
Biology of Blood and Marrow Transplantation. 22 (2016) 3 - p. S312-S313 , 2016

Link: https://doi.org/10.1016/..

13

Pharmacokinetics and Pharmacodynamics with Extended Dosing ..:

Laille, Eric ; Shi, Tao ; Garcia-Manero, Guillermo...
PLOS ONE. 10 (2015) 8 - p. e0135520 , 2015

Link: https://doi.org/10.1371/..

14

Evaluation of CYP3A‐mediated drug–drug interactions with ro..:

Laille, Eric ; Patel, Manish ; Jones, Suzanne F....
The Journal of Clinical Pharmacology. 55 (2015) 12 - p. 1378-1385 , 2015

Link: https://doi.org/10.1002/..

15

Quantitative determination of azacitidine triphosphate in p..:

Derissen, Ellen J.B. ; Hillebrand, Michel J.X. ; Rosing, Hilde...
Journal of Pharmaceutical and Biomedical Analysis. 90 (2014) - p. 7-14 , 2014

Link: https://doi.org/10.1016/..